%0 Journal Article %A Hamish Gibbs %A Emily Nightingale %A Yang Liu %A James Cheshire %A Leon Danon %A Liam Smeeth %A Carl AB Pearson %A Chris Grundy %A LSHTM CMMID COVID-19 working group %A Adam J Kucharski %A Rosalind M Eggo %T Human movement can inform the spatial scale of interventions against COVID-19 transmission %D 2020 %R 10.1101/2020.10.26.20219550 %J medRxiv %P 2020.10.26.20219550 %X The UK enacted an intensive, nationwide lockdown on March 23 2020 to mitigate transmission of COVID-19. As restrictions began to ease, resurgence in transmission has been targeted by geographically-limited interventions of various stringencies. Determining the optimal spatial scale for local interventions is critical to ensure interventions reach the most at risk areas without unnecessarily restricting areas at low risk of resurgence. Here we use detailed human mobility data from Facebook to determine the spatially-explicit network community structure of the UK before and during the lockdown period, and how that has changed in response to the easing of restrictions and to locally-targeted interventions. We found that the mobility network became more sparse and the number of mobility communities decreased under the national lockdown. During this period, there was no evidence of re-routing in the network. Communities in which locally-targeted interventions have happened following resurgence did not show reorganization but did show small decreases in measurable mobility effects in the Facebook dataset. We propose that geographic communities detected in Facebook or other mobility data be part of decision making for determining the spatial extent or boundaries of interventions in the UK. These data are available in near real-time, and allow quantification of changes in the distribution of the population across the UK, as well as people’s travel patterns to give data-driven metrics for geographically-targeted interventions.Significance Statement Large-scale intensive interventions in response to the COVID-19 pandemic have affected human movement patterns. Mobility data show spatially-explicit network structure, but it is not clear if that structure changed in response to national or locally-targeted interventions. We used daily Facebook for Good mobility data to quantify changes in the travel network in the UK during the national lockdown, and in response to local interventions. The network community structure inherent in these networks can help quantify which areas are at risk of resurgence, or the extent of locally-targeted interventions aiming to suppress transmission. We showed that spatial mobility data available in real-time can give information on connectivity that can be used to optimise the scale of geographically-targeted interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe following funding sources are acknowledged as providing funding for the named authors. This research was partly funded by the Bill & Melinda Gates Foundation (INV-003174: YL; NTD Modelling Consortium OPP1184344: CABP; OPP1183986: ESN). DFID/Wellcome Trust (Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z: CABP). This project has received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (101003688: YL). HDR UK (MR/S003975/1: RME). UK DHSC/UK Aid/NIHR (ITCRZ 03010: HPG). UK MRC (MC_PC_19065: RME, YL). Wellcome Trust (206250/Z/17/Z: AJK), UK MRC (MC_PC_19067, LD), The Alan Turing Institute under the EPSRC (grant EP/N510129/1: LD). This research was partly funded by the National Institute for Health Research (NIHR) using UK Aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care (16/137/109: YL; NIHR200908: RME). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was approved by the LSHTM Observational Research Ethics Committee (ref 16834-1).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable on GitHub. %U https://www.medrxiv.org/content/medrxiv/early/2020/10/27/2020.10.26.20219550.full.pdf